Journal article · 2018

Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols

Mahendra S. Rao, Ying Pei, Thelma Y. Garcia, Shereen Chew, Toshiharu Kasai, Tomoko Hisai, Hideki Taniguchi, Takanori Takebe, Deepak A. Lamba, Xianmin Zeng

Cytotherapy, 20(6), 861–872 · Published 21 May 2018 · DOI 10.1016/j.jcyt.2018.03.037

View at the publisherCite this paper

In brief

“Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols” is a 2018 journal article by Mahendra S. Rao and 9 co-authors, published in Cytotherapy. OpenAlex counts 16 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
16
Most cited in
2019 (4)
Field-weighted impact
0.70
References
20
Authors
10

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rao, M. S., Pei, Y., Garcia, T. Y., Chew, S., Kasai, T., Hisai, T., Taniguchi, H., Takebe, T., Lamba, D. A., & Zeng, X. (2018). Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. Cytotherapy, 20(6), 861–872. https://doi.org/10.1016/j.jcyt.2018.03.037

MLA 9

Rao, Mahendra S., et al. “Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.” Cytotherapy, vol. 20, no. 6, 2018, pp. 861–872. https://doi.org/10.1016/j.jcyt.2018.03.037.

Chicago

Rao, Mahendra S., Ying Pei, Thelma Y. Garcia, Shereen Chew, Toshiharu Kasai, Tomoko Hisai, Hideki Taniguchi, Takanori Takebe, Deepak A. Lamba, and Xianmin Zeng. 2018. “Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.” Cytotherapy 20 (6): 861–872. https://doi.org/10.1016/j.jcyt.2018.03.037.

Harvard

Rao, M. S. et al. (2018) ‘Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols’, Cytotherapy, 20(6), pp. 861–872. doi:10.1016/j.jcyt.2018.03.037.

IEEE

M. S. Rao et al., “Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols,” Cytotherapy, vol. 20, no. 6, pp. 861–872, 2018, doi: 10.1016/j.jcyt.2018.03.037.

BibTeX

@article{rao2018illustrating,
  title     = {{Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols}},
  author    = {Rao, Mahendra S. and Pei, Ying and Garcia, Thelma Y. and Chew, Shereen and Kasai, Toshiharu and Hisai, Tomoko and Taniguchi, Hideki and Takebe, Takanori and Lamba, Deepak A. and Zeng, Xianmin},
  journal   = {Cytotherapy},
  year      = {2018},
  volume    = {20},
  number    = {6},
  pages     = {861--872},
  doi       = {10.1016/j.jcyt.2018.03.037},
  url       = {https://doi.org/10.1016/j.jcyt.2018.03.037}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201944
202044
202122
202222
202311
202511
202622

Its field-weighted citation impact is 0.70: it has been cited 0.70 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • induced pluripotent stem cells
  • current good manufacturing practice
  • master cell bank
  • iPSC differentiation
  • neural stem cells
  • dopaminergic neurons
  • astrocytes
  • retinal pigment epithelium

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Rao, M. S., Pei, Y., Garcia, T. Y., Chew, S., Kasai, T., Hisai, T., Taniguchi, H., Takebe, T., Lamba, D. A., & Zeng, X. (2018). Illustrating the potency of current Good Manufacturing Practice–compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. Cytotherapy, 20(6), 861–872. https://doi.org/10.1016/j.jcyt.2018.03.037

How many times has this paper been cited?

16 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Mahendra S. Rao, Ying Pei, Thelma Y. Garcia, Shereen Chew, Toshiharu Kasai, Tomoko Hisai, Hideki Taniguchi, Takanori Takebe, Deepak A. Lamba, Xianmin Zeng.

What is the DOI of this paper?

10.1016/j.jcyt.2018.03.037, permanently at https://doi.org/10.1016/j.jcyt.2018.03.037. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.